Human iPSC-Derived Hippocampal Spheroids: An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies

Yuriy Pomeshchik, Oxana Klementieva, Jeovanis Gil, Isak Martinsson, Marita Grønning Hansen, Tessa de Vries, Anna Sancho-Balsells, Kaspar Russ, Ekaterina Savchenko, Anna Collin, Ana Rita Vaz, Silvia Bagnoli, Benedetta Nacmias, Claire Rampon, Sandro Sorbi, Dora Brites, György Marko-Varga, Zaal Kokaia, Melinda Rezeli, Gunnar K. GourasLaurent Roybon

Research output: Contribution to journalArticlepeer-review

Abstract

In this article, Roybon and colleagues developed a protocol to efficiently and rapidly generate hippocampus neurons from human induced pluripotent stem cells, which they used to model Alzheimer disease and develop a gene therapy approach to modulate the expression of genes involved in synaptic transmission.

Original languageEnglish
Pages (from-to)256-273
Number of pages18
JournalStem Cell Reports
Volume15
Issue number1
DOIs
Publication statusPublished - 2020

Subject classification (UKÄ)

  • Neurosciences
  • Cell and Molecular Biology

Free keywords

  • Alzheimer disease
  • hippocampus
  • iPSC
  • NeuroD1
  • protein aggregation
  • proteomics
  • spheroids
  • transcriptomics
  • viral-mediated gene therapy

Fingerprint

Dive into the research topics of 'Human iPSC-Derived Hippocampal Spheroids: An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies'. Together they form a unique fingerprint.

Cite this